Delivery Order SPE2DB24D1205-SPE2DB25FCZBX
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,535.87, is for the delivery of 4,563,689,418 units of the drug Dicyclomine 20 mg tablet. The contract is a Firm Fixed Price Delivery Order with a completion date of February 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dicyclomine 20 mg/2 mL vials with a ceiling value of $1,590.47. This contract represents a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and was awarded on a competitive basis without set-aside restrictions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This federal contract award is for the delivery of Dicyclomine 20 mg/2 ml ampul 2 ml to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 9, 2025, with a ceiling value of $1,434.46. The contract is a Firm Fixed Price Delivery Order with a completion date of June 10, 2025. This award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,104.99, is for the delivery of DICYCLOMINE HCL INJ5S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a delivery order valued at $13,445.69 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $10,409.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,898.52 to AmerisourceBergen Drug Corp for IBSRELA 50 MG tablets (60-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.01 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product used to treat irritable bowel syndrome. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The award was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,763.74 firm fixed-price delivery order is for the medical product "IBSRELA 50 MG TABLET UU 60S" with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZBXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Dicyclomine 20 mg, a medication commonly used to treat irritable bowel syndrome and related gastrointestinal conditions. This competitively awarded, non-set-aside contract has a ceiling value of $2,388.55 and was finalized on July 30, 2025, with an ultimate completion date of July 31, 2025. The award utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a critical prime pharmaceutical vendor for the Defense Logistics Agency, supplying a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, the company fulfills federal medical procurement needs across multiple therapeutic domains through its established federal contract portfolio with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/30/25 |